Ambu A/S (AMBBY)

Market Cap	3.11B -40.9%
Revenue (ttm)	956.63M +7.8%
Net Income	85.52M +66.9%
EPS	0.32 +67.9%
Shares Out	n/a
PE Ratio	36.40
Forward PE	28.67
Dividend	0.03 (0.30%)
Ex-Dividend Date	Dec 5, 2025

Volume	500
Average Volume	809
Open	11.74
Previous Close	n/a
Day's Range	11.74 - 11.74
52-Week Range	11.49 - 18.05
Beta	1.40
RSI	35.79
Earnings Date	May 6, 2026

About Ambu A/S

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also prov...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1937
• Employees: 5,200
• Stock Exchange: OTCMKTS
• Ticker Symbol: AMBBY

Financial Performance

In fiscal year 2025, Ambu A/S's revenue was 6.04 billion, an increase of 11.98% compared to the previous year's 5.39 billion. Earnings were 609.00 million, an increase of 159.15%.

Financial numbers in DKK